Straight from the Desk

Syz the moment

Live feeds, charts, breaking stories, all day long.

6 Mar 2025

264 of the S&P 500’s constituents, or a little over 52% of the index, are actually still up in 2025.

The star of the S&P 500 Class of Q1 so far is CVS HealthCVS $65.81 (2.74%), which has jumped 45% since the start of the year, closely followed by Philip Morris InternationalPM $153.14 (-0.58%) and Super Micro, which is doing the absolute bare minimum to remain on the market. Uber also joins the all-star lineup, ahead of Meta, which is the best of the Big Tech stocks, evading the pain of peers Amazon (-7%), Nvidia (-14%), and Tesla (-33%), which are all down. But the one company that’s down deepest in the trenches is UGG and Hoka shoe company DeckersDECK $136.40 (1.67%), which never recovered from getting stomped after its underwhelming Q3 update. Source: Chartr

6 Mar 2025

US immigration

Source:: Robin Brooks

6 Mar 2025

Europe's high-debt countries - like France, Italy and Spain - cheer Germany's fiscal expansion.

They're not doing that out of the goodness of their hearts. Germany now can't possibly say no to more joint EU debt issuance. A win for high-debt countries and their muddle through... Source: Robin Brooks

6 Mar 2025

⚠️The famous Trade War Cycle is back in full swing...

Source: Global Markets Investor

6 Mar 2025

Another big move today

US dollar around the start of Trump 1.0 and 2.0

6 Mar 2025

US economic data related to the CONSUMER has surprised to the DOWNSIDE by the most in over 2 years.

This comes as Americans pulled back on spending due to deteriorating labor market conditions and high inflation. 🚨Spending reflects 2/3 of the US GDP. Source: Global Markets Investor, Goldman Sachs

6 Mar 2025

EU defence stocks so far this year....

Source: Koyfin

6 Mar 2025

2025 returns by country:

Germany +21% Italy +19% France +17% UK +12% US -0.5% Source: Ben Carlson @awealthofcs

Thinking out loud

Sign up for our weekly email highlighting the most popular posts.

Follow us

Thinking out loud

Investing with intelligence

Our latest research, commentary and market outlooks